Financial Ratios Bolt Biotherapeutics, Inc.

Equities

BOLT

US0977022039

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:30:00 05/12/2025 GMT			5-day change	1st Jan Change
5.420 ^USD	+2.07%		+6.90%	-49.36%

11-12	Bolt Biotherapeutics Q3 collaboration revenue doubles	RE
11-12	Bolt Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

eef06d76da74a3b82474990f4.uM0hKn8U8I7IxnUFSFWkJNBFmT9f1jdTW_Ua_DPcjFM.8JtTWzQlw9yZrRx_FyOVQZsmyGgMkEMWHL9_ulbsxzrOp2RvHE64xYWrNA

Published financial data: BOLT BIOTHERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	231K	1.26M	5.73M	7.88M	7.69M
Total Revenues	231K	1.26M	5.73M	7.88M	7.69M
Cost of Goods Sold, Total	40.36M	75.66M	73.12M	61.54M	57.47M
Gross Profit	-40.13M	-74.4M	-67.39M	-53.67M	-49.78M
Selling General & Admin Expenses, Total	9.06M	18.39M	22.93M	22.53M	18.46M
Other Operating Expenses, Total	9.06M	18.39M	22.93M	22.53M	18.46M
Operating Income	-49.18M	-92.79M	-90.32M	-76.2M	-68.24M
Interest And Investment Income	199K	281K	2.22M	7M	5.26M
Net Interest Expenses	199K	281K	2.22M	7M	5.26M
Other Non Operating Income (Expenses)	-11.74M	-6.08M	-	-	-
EBT, Excl. Unusual Items	-60.73M	-98.59M	-88.1M	-69.2M	-62.98M
Restructuring Charges	-	-	-	-	-3.34M
Asset Writedown	-	-	-	-	-1.47M
Other Unusual Items	-	-	-	-	4.68M
EBT, Incl. Unusual Items	-60.73M	-98.59M	-88.1M	-69.2M	-63.12M
Earnings From Continuing Operations	-60.73M	-98.59M	-88.1M	-69.2M	-63.12M
Net Income to Company	-60.73M	-98.59M	-88.1M	-69.2M	-63.12M
Net Income - (IS)	-60.73M	-98.59M	-88.1M	-69.2M	-63.12M
Net Income to Common Incl Extra Items	-60.73M	-98.59M	-88.1M	-69.2M	-63.12M
Net Income to Common Excl. Extra Items	-60.73M	-98.59M	-88.1M	-69.2M	-63.12M
Per Share Items
Net EPS - Basic	-577.72	-59.4	-47.16	-36.6	-33.06
Basic EPS - Continuing Operations	-577.72	-59.4	-47.16	-36.6	-33.06
Basic Weighted Average Shares Outstanding	105K	1.66M	1.87M	1.89M	1.91M
Net EPS - Diluted	-577.72	-59.4	-47.16	-36.6	-33.06
Diluted EPS - Continuing Operations	-577.72	-59.4	-47.16	-36.6	-33.06
Diluted Weighted Average Shares Outstanding	105K	1.66M	1.87M	1.89M	1.91M
Normalized Basic EPS	-361.08	-37.12	-29.48	-22.88	-20.62
Normalized Diluted EPS	-361.08	-37.12	-29.48	-22.88	-20.62
Supplemental Items
EBITDA	-48.57M	-91.6M	-88.66M	-74.34M	-66.46M
EBITA	-49.18M	-92.79M	-90.32M	-76.2M	-68.24M
EBIT	-49.18M	-92.79M	-90.32M	-76.2M	-68.24M
EBITDAR	-46.26M	-88.55M	-85.11M	-70.66M	-62.33M
Normalized Net Income	-37.96M	-61.62M	-55.06M	-43.25M	-39.36M
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	9.06M	18.39M	22.93M	22.53M	18.46M
Research And Development Expense From Footnotes	40.36M	75.66M	73.12M	61.54M	57.47M
Net Rental Expense, Total	2.31M	3.04M	3.55M	3.68M	4.12M
Stock-Based Comp., COGS (Total)	734K	4.46M	4.11M	3.7M	3.15M
Stock-Based Comp., G&A Exp. (Total)	686K	4.04M	5.47M	5.52M	4.26M
Total Stock-Based Compensation	1.42M	8.5M	9.58M	9.22M	7.41M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	5.54M	27.38M	9.24M	10.81M	7.2M
Short Term Investments	17.3M	159M	160M	91.38M	40.12M
Total Cash And Short Term Investments	22.84M	186M	169M	102M	47.32M
Other Receivables	12K	200K	800K	1.3M	808K
Total Receivables	12K	200K	800K	1.3M	808K
Prepaid Expenses	2.51M	2.74M	3.06M	2.04M	1.84M
Restricted Cash	-	-	-	-	784K
Other Current Assets, Total	-	-	-	178K	55K
Total Current Assets	25.36M	189M	173M	106M	50.81M
Gross Property Plant And Equipment	17.62M	32.85M	32.44M	29.83M	32.17M
Accumulated Depreciation	-1.24M	-2.24M	-3.92M	-5.75M	-7.28M
Net Property Plant And Equipment	16.38M	30.6M	28.52M	24.08M	24.9M
Long-term Investments	-	85.35M	23.94M	26.41M	22.88M
Deferred Charges Long-Term	2.36M	-	-	371K	51K
Other Long-Term Assets, Total	2.44M	2.61M	2.59M	3.22M	992K
Total Assets	46.54M	308M	228M	160M	99.63M
Liabilities
Accounts Payable, Total	1.6M	3.57M	3.59M	2.99M	1.51M
Accrued Expenses, Total	6.66M	12.38M	15.14M	12.49M	8.34M
Current Portion of Leases	1.5M	2.5M	2.39M	2.78M	2.25M
Unearned Revenue Current, Total	1.5M	2.87M	1.99M	2.2M	3.02M
Other Current Liabilities	-	-	-	-	739K
Total Current Liabilities	11.26M	21.33M	23.12M	20.46M	15.86M
Long-Term Leases	9.38M	21.85M	20.22M	17.44M	22.96M
Unearned Revenue Non Current	-	14.21M	12.92M	9.11M	3.62M
Other Non Current Liabilities	329K	210K	42K	43K	-
Total Liabilities	20.97M	57.6M	56.3M	47.04M	42.43M
Preferred Stock Convertible	105M	-	-	-	-
Preferred Stock - Others	25.22M	-	-	-	-
Total Preferred Equity	131M	-	-	-	-
Common Stock, Total	-	-	-	1K	-
Additional Paid In Capital	3.45M	457M	468M	477M	485M
Retained Earnings	-108M	-207M	-295M	-364M	-427M
Comprehensive Income and Other	-	-321K	-919K	37K	97K
Total Common Equity	-105M	250M	172M	113M	57.2M
Total Equity	25.57M	250M	172M	113M	57.2M
Total Liabilities And Equity	46.54M	308M	228M	160M	99.63M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.82M	1.87M	1.89M	1.91M	1.92M
ECS Total Common Shares Outstanding	107K	1.87M	1.89M	1.91M	1.92M
Book Value / Share	-985.35	133.75	90.75	59.16	29.84
Tangible Book Value	-105M	250M	172M	113M	57.2M
Tangible Book Value Per Share	-985.35	133.75	90.75	59.16	29.84
Total Debt	10.88M	24.36M	22.61M	20.22M	25.21M
Net Debt	-11.96M	-162M	-146M	-81.97M	-22.11M
Debt Equivalent Oper. Leases	18.46M	24.34M	28.37M	29.44M	32.98M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	5.32M	8.26M	10.1M	10.42M	10.13M
Full Time Employees	65	91	94	100	52

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-60.73M	-98.59M	-88.1M	-69.2M	-63.12M
Depreciation & Amortization - CF	611K	1.19M	1.67M	1.85M	1.78M
Depreciation & Amortization, Total	611K	1.19M	1.67M	1.85M	1.78M
(Gain) Loss From Sale Of Asset	-	108K	-	-	-70K
(Gain) Loss on Sale of Investments - (CF)	34K	2.65M	184K	-4.49M	-2.62M
Asset Writedown & Restructuring Costs	-	-	-	-	1.47M
Stock-Based Compensation (CF)	1.42M	8.5M	9.58M	9.22M	7.41M
Other Operating Activities, Total	13.64M	8.56M	3.22M	2.95M	2.3M
Change In Accounts Payable	2.88M	6.68M	2.77M	-3.41M	-4.88M
Change in Unearned Revenues	-69K	15.57M	-2.16M	-3.61M	-4.67M
Change in Other Net Operating Assets	-5.1M	-1.74M	-3.66M	-2.84M	1.12M
Cash from Operations	-47.31M	-57.07M	-76.5M	-69.52M	-61.29M
Capital Expenditure	-3.26M	-2.34M	-1.95M	-206K	-41K
Sale of Property, Plant, and Equipment	-	-	-	-	148K
Investment in Marketable and Equity Securities, Total	-17.33M	-230M	59.82M	71.24M	57.47M
Cash from Investing	-20.59M	-232M	57.86M	71.04M	57.58M
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	294K	259M	503K	253K	108K
Issuance of Preferred Stock	41.27M	51.9M	-	-	-
Other Financing Activities, Total	-1.97M	-	-	-	-
Cash from Financing	39.6M	311M	503K	253K	108K
Net Change in Cash	-28.3M	21.84M	-18.14M	1.77M	-3.6M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Levered Free Cash Flow	-29.22M	-41.99M	-46.18M	-39.47M	-37.54M
Unlevered Free Cash Flow	-29.22M	-41.99M	-46.18M	-39.47M	-37.54M
Change In Net Working Capital	-2.75M	-8.65M	-983K	2.71M	4.04M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-64.72	-32.74	-21.08	-24.57	-32.88
Return on Total Capital	-78.52	-37.3	-24.09	-29.12	-39.6
Return On Equity %	-212.22	-71.52	-41.79	-48.69	-74.28
Return on Common Equity	80.54	-135.83	-41.79	-48.69	-74.28
Margin Analysis
Gross Profit Margin %	-17.37K	-5.9K	-1.18K	-681.39	-647.32
SG&A Margin	3.92K	1.46K	400.19	286.06	240.01
EBITDA Margin %	-21.03K	-7.27K	-1.55K	-943.91	-864.17
EBITA Margin %	-21.29K	-7.36K	-1.58K	-967.45	-887.33
EBIT Margin %	-21.29K	-7.36K	-1.58K	-967.45	-887.33
Income From Continuing Operations Margin %	-26.29K	-7.82K	-1.54K	-878.58	-820.78
Net Income Margin %	-26.29K	-7.82K	-1.54K	-878.58	-820.78
Net Avail. For Common Margin %	-26.29K	-7.82K	-1.54K	-878.58	-820.78
Normalized Net Income Margin	-16.43K	-4.89K	-961.1	-549.11	-511.87
Levered Free Cash Flow Margin	-12.65K	-3.33K	-806.05	-501.09	-488.19
Unlevered Free Cash Flow Margin	-12.65K	-3.33K	-806.05	-501.09	-488.19
Asset Turnover
Asset Turnover	0	0.01	0.02	0.04	0.06
Fixed Assets Turnover	0.02	0.05	0.19	0.3	0.31
Short Term Liquidity
Current Ratio	2.25	8.87	7.47	5.17	3.2
Quick Ratio	2.03	8.74	7.34	5.06	3.04
Operating Cash Flow to Current Liabilities	-4.2	-2.68	-3.31	-3.4	-3.87
Average Days Payable Outstanding	16.75	12.48	17.89	19.52	14.31
Long Term Solvency
Total Debt/Equity	42.53	9.74	13.18	17.93	44.07
Total Debt / Total Capital	29.84	8.87	11.65	15.21	30.59
LT Debt/Equity	36.66	8.74	11.79	15.47	40.14
Long-Term Debt / Total Capital	25.72	7.96	10.42	13.11	27.86
Total Liabilities / Total Assets	45.05	18.72	24.71	29.44	42.59
Total Debt / EBITDA	-0.24	-0.28	-0.27	-0.29	-0.4
Net Debt / EBITDA	0.26	1.83	1.72	1.16	0.35
Total Debt / (EBITDA - Capex)	-0.22	-0.27	-0.26	-0.29	-0.4
Net Debt / (EBITDA - Capex)	0.24	1.78	1.68	1.16	0.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	7.44	445.45	354.68	37.48	-2.36
Gross Profit, 1 Yr. Growth %	55.61	85.4	-9.41	-20.37	-7.24
EBITDA, 1 Yr. Growth %	58.55	88.58	-3.21	-16.14	-10.61
EBITA, 1 Yr. Growth %	58.81	88.66	-2.66	-15.64	-10.45
EBIT, 1 Yr. Growth %	58.81	88.66	-2.66	-15.64	-10.45
Earnings From Cont. Operations, 1 Yr. Growth %	99.19	62.35	-10.64	-21.45	-8.79
Net Income, 1 Yr. Growth %	99.19	62.35	-10.64	-21.45	-8.79
Normalized Net Income, 1 Yr. Growth %	99.19	62.35	-10.64	-21.45	-8.98
Diluted EPS Before Extra, 1 Yr. Growth %	88.88	-89.72	-20.6	-22.4	-9.67
Net Property, Plant and Equip., 1 Yr. Growth %	42.26	87.17	-6.79	-15.59	3.4
Total Assets, 1 Yr. Growth %	-3.93	561.16	-25.97	-29.86	-37.65
Tangible Book Value, 1 Yr. Growth %	128.91	-338.33	-31.43	-34.26	-49.27
Common Equity, 1 Yr. Growth %	128.91	-338.33	-31.43	-34.26	-49.27
Cash From Operations, 1 Yr. Growth %	79.58	20.63	34.06	-9.12	-11.85
Capital Expenditures, 1 Yr. Growth %	542.13	-28.33	-16.47	-89.45	-80.1
Levered Free Cash Flow, 1 Yr. Growth %	85.03	43.73	9.97	-14.54	-4.88
Unlevered Free Cash Flow, 1 Yr. Growth %	85.03	43.73	9.97	-14.54	-4.88
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	142.08	398	150.02	15.86
Gross Profit, 2 Yr. CAGR %	106.39	69.85	29.6	-15.07	-14.06
EBITDA, 2 Yr. CAGR %	107.08	72.92	35.1	-9.91	-13.42
EBITA, 2 Yr. CAGR %	105.65	73.09	35.52	-9.38	-13.08
EBIT, 2 Yr. CAGR %	105.65	73.09	35.52	-9.38	-13.08
Earnings From Cont. Operations, 2 Yr. CAGR %	128.91	79.83	20.44	-16.22	-15.36
Net Income, 2 Yr. CAGR %	128.91	79.83	20.44	-16.22	-15.36
Normalized Net Income, 2 Yr. CAGR %	128.91	79.83	20.44	-16.22	-15.45
Diluted EPS Before Extra, 2 Yr. CAGR %	102.85	-55.93	-71.43	-21.5	-16.28
Net Property, Plant and Equip., 2 Yr. CAGR %	237.08	63.01	32.09	-11.3	-6.58
Total Assets, 2 Yr. CAGR %	70.69	152.02	121.24	-27.94	-33.87
Tangible Book Value, 2 Yr. CAGR %	156.57	133.57	27.84	-32.86	-42.25
Common Equity, 2 Yr. CAGR %	156.57	133.57	27.84	-32.86	-42.25
Cash From Operations, 2 Yr. CAGR %	118.91	47.18	27.17	10.38	-10.49
Capital Expenditures, 2 Yr. CAGR %	235.38	114.53	-22.62	-70.32	-85.51
Levered Free Cash Flow, 2 Yr. CAGR %	-	63.08	25.72	-3.05	-9.84
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	63.08	25.72	-3.05	-9.84
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	198.68	224.26	82.75
Gross Profit, 3 Yr. CAGR %	-	99.14	37.74	10.18	-12.54
EBITDA, 3 Yr. CAGR %	-	100.72	42.51	15.24	-10.14
EBITA, 3 Yr. CAGR %	-	99.82	42.87	15.71	-9.74
EBIT, 3 Yr. CAGR %	-	99.82	42.87	15.71	-9.74
Earnings From Cont. Operations, 3 Yr. CAGR %	-	104.14	42.44	4.45	-13.81
Net Income, 3 Yr. CAGR %	-	104.14	42.44	4.45	-13.81
Normalized Net Income, 3 Yr. CAGR %	-	104.14	42.44	4.45	-13.88
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-24.93	-46.38	-60.14	-17.74
Net Property, Plant and Equip., 3 Yr. CAGR %	-	176.86	35.3	13.77	-6.65
Total Assets, 3 Yr. CAGR %	-	168.06	67.53	50.86	-31.33
Tangible Book Value, 3 Yr. CAGR %	-	150.34	55.24	2.42	-38.85
Common Equity, 3 Yr. CAGR %	-	150.34	55.24	2.42	-38.85
Cash From Operations, 3 Yr. CAGR %	-	79.47	42.67	13.69	2.41
Capital Expenditures, 3 Yr. CAGR %	-	100.52	56.66	-60.18	-74.02
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	43.01	10.54	-3.67
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	43.01	10.54	-3.67
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	104.5
Gross Profit, 5 Yr. CAGR %	-	-	-	41.62	14.06
EBITDA, 5 Yr. CAGR %	-	-	-	45.69	16.75
EBITA, 5 Yr. CAGR %	-	-	-	45.64	17.12
EBIT, 5 Yr. CAGR %	-	-	-	45.64	17.12
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	42.96	15.67
Net Income, 5 Yr. CAGR %	-	-	-	42.96	15.67
Normalized Net Income, 5 Yr. CAGR %	-	-	-	42.96	15.62
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-23.58	-35.92
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	75.6	16.67
Total Assets, 5 Yr. CAGR %	-	-	-	58.5	15.51
Tangible Book Value, 5 Yr. CAGR %	-	-	-	47.88	4.52
Common Equity, 5 Yr. CAGR %	-	-	-	47.88	4.52
Cash From Operations, 5 Yr. CAGR %	-	-	-	47.76	18.4
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-6.61	-39.55
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	18.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	18.91